［1］Zappella M, Meloni I, Longo I, Canitano R, Hayek G, Rosaia L, et al. Study of MECP2 gene in Rett syndrome variants and autistic girls［J］. Am J Med Genet Part B Neuropsychiatr Genet, 2003, 119B(1):102-107.
［2］Cardaioli E, Dotti MT, Hayek G, Zappella M, Federico A. Studies on mitochondrial pathogenesis of Rett syndrome: ultrastructural data from skin and muscle biopsies and mutational analysis at mt-DNA nucleotides 10463 and 2835［J］. J Submicrosc Cytol Pathol, 1999, 31(2):301-304.
［3］孟洪弟，戚豫，潘虹，武期专，吴希如. Rett综合征患儿线粒体结构及功能缺陷的研究［J］. 中华儿科杂志，2001，39(9)：518-521.
［4］Ellaway CJ, Peat J, Williams K, Leonard H, Christodoulou J. Medium-term open label trial of L-carnitine in Rett syndrome［J］. Brain Dev, 2001, 23 (Suppl 1):S85-89.
［5］包新华，潘虹，宋福英，吴希如. Rett综合征的临床特征及MeCP2的基因型与表型的关系研究［J］. 中华儿科杂志，2004，42（4）：252-255.
［6］Tsai SJ. Lithium and antidepressants: potential agents for the treatment of Rett syndrome［J］. Med Hypotheses, 2006, 67(3):626-629.
［7］Antonova SV, Akhalaia MIa, Baǐzhumanov AA, Shestakova SV, Goncharenko EN, Krushinskaia IaV, et al. Functional and biochemical correlates of hypoxic shock: cooperative effect of the regulatory peptides［J］. Biull Eksp Biol Med, 1997, 124(10):400-402.
［8］Dolotov OV, Karpenko EA, Seredenina TS, Inozemtseva LS, Levitskaya NG, Zolotarev YA, et al. Semax, an analogue of adrenocorticotropin (4-10), binds specifically and increases levels of brain-derived neurotrophic factor protein in rat basal forebrain［J］. J Neurochem, 2006, 97(Suppl 1):82-86.
［9］Shadrina MI, Dolotov OV, Grivennikov IA, Slominsky PA, Andreeva LA, Inozemtseva LS, et al. Rapid induction of neurotrophin mRNAs in glial cell cultures by Semax, an adrenocorticotropic hormone analog［J］. Neurosci Lett, 2001, 308(2):115-118.
［10］Miasoedova NF, Skvortsova VI, Nasonov EL, Zhuravleva EIu, Grivennikov IA, Arsen′eva EL,  et al. Investigation of mechanisms of neuro-protective effect of semax in acute period of ischemic stroke［J］.Zh Nevrol Psikhiatr Im S S Korsakova, 1999, 99(5):15-19.
［11］Antonova SV, Akhalaia MIa, Baǐzhumanov AA, Shestakova SV, Goncharenko EN, Krushinskaia IaV, et al. Functional and biochemical correlates of hypoxic shock: cooperative effect of the regulatory peptides［J］. Biull Eksp Biol Med, 1997, 124(10):400-402.
［12］Tsai SJ. Semax, an analogue of adrenocorticotropin (4-10), is a potential agent for the treatment of attention-deficit hyperactivity disorder and Rett syndrome［J］. Med Hypotheses, 2007, 68(5):1144-1146.
［13］Potaman VN, Alfeeva LY, Kamensky AA, Levitzkaya NG, Nezavibatko VN. N-terminal degradation of ACTH(4-10) and its synthetic analog Semax by the rat blood enzymes［J］. Biochem Biophys Res Commun, 1991, 176(2):741-746.